Tocagen Phase III study in brain cancer fails, sending shares plummeting – MedCity News

Tocagen Phase III study in brain cancer fails, sending shares plummeting – MedCity News
Tocagen Phase III study in brain cancer fails, sending shares plummeting  MedCity NewsThe company said Thursday morning that its study failed to meet its primary endpoint in high-grade gliomas. Shares of the company fell more than 80 percent on …
Tocagen Phase III study in brain cancer fails, sending shares plummeting – MedCity News